<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00324701</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 04-421</org_study_id>
    <secondary_id>HR16402</secondary_id>
    <nct_id>NCT00324701</nct_id>
  </id_info>
  <brief_title>Telepsychology-Service Delivery for Depressed Elderly Veterans</brief_title>
  <official_title>Telepsychology-Service Delivery for Depressed Elderly Veterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see whether therapy for elderly adults with major depression
      can be delivered effectively using videoconferencing technology (&quot;telepsychology&quot;), which
      allows a therapist and patient who are not in the same room as one another to communicate. We
      are interested in learning if this form of mental health service delivery is an acceptable
      alternative to traditional face-to-face therapy delivered with the therapist in the same room
      as the patient.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ABSTRACT

      Telepsychology: Service Delivery for Depressed Elderly Veterans

        1. Objective: The immediate objective is to test the hypothesis that a novel mode of
           geriatric mental health service delivery, using in-home videoconferencing technology
           (&quot;Telepsychology&quot;), will be as effective as the traditional mode of service delivery
           (&quot;Same-Room&quot;) for treating older adult veterans suffering from major depressive disorder
           (MDD). The ultimate objective is to help the VA develop and evaluate strategies for
           providing mental health care to elderly veterans who live in rural areas, many of whom
           are minorities.

        2. Research Design: This project is a 4-year prospective, randomized between-groups study
           comparing the efficacy of an intervention for geriatric depression delivered via two
           different modes (Telepsychology, Same-Room). Participants in the Telepsychology
           condition will receive care in their own home via videophone contact with a therapist at
           the Charleston VA Medical Center; participants in the Same-room condition will receive
           their care via traditional face-to-face therapy sessions held at the Charleston VA
           Medical Center. Two-hundred twenty-four (224) participants will be recruited from
           primary care and mental health clinics within the Charleston VA Medical Center catchment
           area. Treatment will be administered over an 8-week period (active treatment phase); and
           participants will be followed for an additional 12-months (follow-up phase) to ascertain
           longer-term effects of treatment on three outcome domains: (1) clinical outcomes:
           symptom severity and social functioning; (2) process outcomes: patient satisfaction and
           acceptance, treatment credibility, session attendance, treatment adherence, and
           treatment dropout; and (3) cost-effectiveness.

        3. Methodology: Population and Sample: Participants will be elderly veterans (N = 224), age
           60 and above, with diagnoses of major depressive disorder (MDD). Based on our previous
           research and local demographics, we expect approximately 40% of our sample will be
           African-American. Types of Data: To assess outcome, we will use measures that have been
           widely validated in the clinical evaluation of older adults with MDD. Measures will be
           collected at pre-treatment, post-treatment, 3-, and 12-month follow-up. Data Analyses
           Plan: The primary clinical response variable is proportion (%) of patients who respond
           to treatment, where treatment response is defined as at least a 50% improvement from
           baseline to post-treatment level on the GDS (percent change from
           baseline:[baseline-post]/baseline &gt;= 50%). Two approaches to estimation of the primary
           response variable will be taken. The first approach will estimate proportion of
           responders (% responders) at the end of the 8-week active treatment course based on the
           total number randomized to each treatment. This is equivalent to a &quot;worst case&quot; analysis
           in which all premature exits (for whom response status is missing) will be treated as
           non-responders. We will also estimate proportion of responders for each treatment based
           on only those who complete the 8-week treatment course (completer analysis). The second
           approach will use multivariable logistic regression to estimate adjusted % responders.
           Finally, we will conduct a range of analyses between African-American and Caucasian
           subjects to look at differential efficacy, patient preferences and satisfaction, and
           adherence across racial groups.

        4. Findings: Analysis of data is currently in process.

        5. Clinical Relationship: Findings will allow for improved service delivery and access to
           elderly depressed veterans.

        6. Impact/Significance: The telepsychology literature is undeveloped. The VA has made
           telehealth a priority strategy for bringing quality services to veterans in rural areas.
           Therefore, research that addresses the efficacy of this mode of service delivery is
           acutely needed. If Telepsychology efficacy and cost-effectiveness is demonstrated, then
           future research and program development will bring specialized mental health services to
           the homes of minority veterans or VA community based outpatient clinics. Further, if
           Telepsychology effectiveness can be empirically established, then we can proceed with
           research that examines a range of important system issues. Thus, this project represents
           a step in a major programmatic line of research in mental health service delivery to
           rural and underserved populations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>At Least a 50% Improvement From Baseline to Post-treatment on the Geriatric Depression Scale (GDS)</measure>
    <time_frame>8 week &amp; 12 months</time_frame>
    <description>The Geriatric Depression Scale (GDS) is a 30-item self-report assessment designed specifically to identify depression in the elderly. Participants are asked to respond by answering yes or no in reference to how they felt over the past week. Higher scores indicate more severe depression.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SCID: Structured Clinical Interview for the DSM-IV</measure>
    <time_frame>12 months</time_frame>
    <description>Structured clinical interview for the DSM-IV (SCID) administered by raters blind to subject condition. Structured interviews included psychiatric assessment for depression, PTSD, panic, generalized anxiety disorder (GAD) evaluated using the DSM-IV.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">241</enrollment>
  <condition>Depression</condition>
  <condition>Elderly</condition>
  <arm_group>
    <arm_group_label>Telepsychology</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>therapy done at patients house</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Face-to-face therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>therapy delivered at the VAMC</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Telepsychology</intervention_name>
    <description>therapy done at patients house</description>
    <arm_group_label>Telepsychology</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Face-to-face therapy</intervention_name>
    <description>therapy delivered at the VAMC</description>
    <arm_group_label>Face-to-face therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants will be older male and female veterans,

          -  age 60 and above,

          -  with diagnoses of major depressive disorder (MDD) assigned on the basis of the
             Structured Clinical Interview for DSM-IV (SCID; Spitzer et al., 1997).

        Exclusion Criteria:

          -  Actively psychotic or demented persons,

          -  individuals with both suicidal ideation and clear intent, and

          -  individuals meeting criteria for substance dependence will be excluded from
             participation.

        However, in order to maximize generalization of results, presence of other forms of
        psychopathology will not be a basis for exclusion. All of these structured interviews will
        be audiotaped in order to calculate inter-rater reliability on a randomly selected 20%.
        (See Human Subjects for procedures in place for suicidal participants or potential
        participants).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonard E. Egede, MD MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ralph H. Johnson VA Medical Center, Charleston, SC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ralph H. Johnson VA Medical Center, Charleston, SC</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29401-5799</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Cluver JS, Schuyler D, Frueh BC, Brescia F, Arana GW. Remote psychotherapy for terminally ill cancer patients. J Telemed Telecare. 2005;11(3):157-9.</citation>
    <PMID>15901444</PMID>
  </reference>
  <results_reference>
    <citation>Egede LE, Frueh CB, Richardson LK, Acierno R, Mauldin PD, Knapp RG, Lejuez C. Rationale and design: telepsychology service delivery for depressed elderly veterans. Trials. 2009 Apr 20;10:22. doi: 10.1186/1745-6215-10-22.</citation>
    <PMID>19379517</PMID>
  </results_reference>
  <results_reference>
    <citation>Richardson LK, Frueh BC, Grubaugh AL, Egede L, Elhai JD. Current Directions in Videoconferencing Tele-Mental Health Research. Clin Psychol (New York). 2009 Sep 1;16(3):323-338.</citation>
    <PMID>20161010</PMID>
  </results_reference>
  <results_reference>
    <citation>Osborn CY, Egede LE. The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support. Gen Hosp Psychiatry. 2012 May-Jun;34(3):249-53. doi: 10.1016/j.genhosppsych.2012.01.015. Epub 2012 Mar 7.</citation>
    <PMID>22401705</PMID>
  </results_reference>
  <results_reference>
    <citation>Tuerk PW, Gros DF, Acierno RE, Strachan MK, Egede LE, Morland LA, Greene CJ, Myrick DL, Frueh BC. Delivery of evidence-based psychotherapy via video telehealth. Journal of psychopathology and behavioral assessment. 2013 Dec 1; 35(4):506-521.</citation>
  </results_reference>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2006</study_first_submitted>
  <study_first_submitted_qc>May 9, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2006</study_first_posted>
  <results_first_submitted>November 6, 2014</results_first_submitted>
  <results_first_submitted_qc>November 24, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 26, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mental Health</keyword>
  <keyword>Geriatric Medicine</keyword>
  <keyword>Depression</keyword>
  <keyword>Health Service Delivery</keyword>
  <keyword>Aged</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Telepsychology</title>
          <description>therapy done at patients house using in-home video conferencing technology</description>
        </group>
        <group group_id="P2">
          <title>Face-to-face Therapy</title>
          <description>therapy delivered at the VAMC in the same room as the therapist</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="121"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Week 8 Assessment</title>
              <participants_list>
                <participants group_id="P1" count="108"/>
                <participants group_id="P2" count="107"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
                <participants group_id="P2" count="104"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Older adult Veterans (age 60 or older) presenting for services at VA primary care clinics and meeting DSM-IV criteria for major depressive disorder.</population>
      <group_list>
        <group group_id="B1">
          <title>Telepsychology</title>
          <description>therapy done at patients house using in-home video conferencing technology</description>
        </group>
        <group group_id="B2">
          <title>Face-to-face Therapy</title>
          <description>therapy delivered at the VAMC in the same room as the therapist</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="120"/>
            <count group_id="B2" value="121"/>
            <count group_id="B3" value="241"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.5" spread="4.4"/>
                    <measurement group_id="B2" value="64.2" spread="5.6"/>
                    <measurement group_id="B3" value="63.9" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="116"/>
                    <measurement group_id="B2" value="119"/>
                    <measurement group_id="B3" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="75"/>
                    <measurement group_id="B3" value="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.5" spread="2.3"/>
                    <measurement group_id="B2" value="13.8" spread="2.9"/>
                    <measurement group_id="B3" value="13.7" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Income</title>
          <description>Not all participants answered the question, which explains the discrepancy in total number</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>$0 - &lt; $15,000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>$15,000 - &lt; $25,000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>$25,000 - &lt; $$50,000</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>$50,000 or more</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>At Least a 50% Improvement From Baseline to Post-treatment on the Geriatric Depression Scale (GDS)</title>
        <description>The Geriatric Depression Scale (GDS) is a 30-item self-report assessment designed specifically to identify depression in the elderly. Participants are asked to respond by answering yes or no in reference to how they felt over the past week. Higher scores indicate more severe depression.</description>
        <time_frame>8 week &amp; 12 months</time_frame>
        <population>Participants completing 8 week and 12 month assessments.</population>
        <group_list>
          <group group_id="O1">
            <title>Telepsychology</title>
            <description>therapy done at patients house using in-home video conferencing technology</description>
          </group>
          <group group_id="O2">
            <title>Face-to-face Therapy</title>
            <description>therapy delivered at the VAMC in the same room as the therapist</description>
          </group>
        </group_list>
        <measure>
          <title>At Least a 50% Improvement From Baseline to Post-treatment on the Geriatric Depression Scale (GDS)</title>
          <description>The Geriatric Depression Scale (GDS) is a 30-item self-report assessment designed specifically to identify depression in the elderly. Participants are asked to respond by answering yes or no in reference to how they felt over the past week. Higher scores indicate more severe depression.</description>
          <population>Participants completing 8 week and 12 month assessments.</population>
          <units>% participants with treatment response</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
                <count group_id="O2" value="107"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>8 weeks</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.6" lower_limit="11.6" upper_limit="23.6"/>
                    <measurement group_id="O2" value="22.4" lower_limit="15.8" upper_limit="29.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.0" lower_limit="15.2" upper_limit="28.8"/>
                    <measurement group_id="O2" value="20.2" lower_limit="13.7" upper_limit="26.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SCID: Structured Clinical Interview for the DSM-IV</title>
        <description>Structured clinical interview for the DSM-IV (SCID) administered by raters blind to subject condition. Structured interviews included psychiatric assessment for depression, PTSD, panic, generalized anxiety disorder (GAD) evaluated using the DSM-IV.</description>
        <time_frame>12 months</time_frame>
        <population>Participants completing 12 month assessment</population>
        <group_list>
          <group group_id="O1">
            <title>Telepsychology</title>
            <description>therapy done at patients house using in-home video conferencing technology</description>
          </group>
          <group group_id="O2">
            <title>Face-to-face Therapy</title>
            <description>therapy delivered at the VAMC in the same room as the therapist</description>
          </group>
        </group_list>
        <measure>
          <title>SCID: Structured Clinical Interview for the DSM-IV</title>
          <description>Structured clinical interview for the DSM-IV (SCID) administered by raters blind to subject condition. Structured interviews included psychiatric assessment for depression, PTSD, panic, generalized anxiety disorder (GAD) evaluated using the DSM-IV.</description>
          <population>Participants completing 12 month assessment</population>
          <units>% participants with treatment response</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50" lower_limit="41.8" upper_limit="58.2"/>
                    <measurement group_id="O2" value="44.2" lower_limit="36.2" upper_limit="52.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Telepsychology</title>
          <description>therapy done at patients house using in-home video conferencing technology</description>
        </group>
        <group group_id="E2">
          <title>Face-to-face Therapy</title>
          <description>therapy delivered at the VAMC in the same room as the therapist</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="121"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="121"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Leonard E. Egede, MD, MS</name_or_title>
      <organization>Ralph H. Johnson VAMC</organization>
      <phone>843-789-6670</phone>
      <email>Leonard.Egede@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

